Literature DB >> 16305062

Contrasting clinical and cardiovascular risk status between early and later onset type 2 diabetes.

Mensud Hatunic1, Nicole Burns, Francis Finucane, Cynthia Mannion, John J Nolan.   

Abstract

The prevalence of type 2 diabetes (T2DM) is increasing rapidly and the age of presentation is falling. These changes are likely to be linked to the current obesity epidemic. Our objective was to compare the characteristics of younger patients with T2DM (diagnosed at age < 40 years) with those of older patients (diagnosed at age 50-70 years). We identified 149 younger patients with T2DM, from our diabetes clinic database, and compared them with 217 older T2DM patients randomly identified from the same database. Younger patients with T2DM were more obese, more hypertriglyceridaemic, with lower high-density lipoprotein (HDL) cholesterol, higher total cholesterol/HDL ratio and worse initial and ongoing glycaemic control than older patients from the same clinic. Additional cardiovascular risk factors are associated with T2DM in the young. Treatment should be aimed at early modification of lifestyle and other forms of therapy to avoid long-term complications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305062     DOI: 10.3132/dvdr.2005.012

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  15 in total

1.  Fighting the battle of the bulge: exercise training in early-onset type 2 diabetes.

Authors:  M E Osler; J R Zierath
Journal:  Diabetologia       Date:  2007-07       Impact factor: 10.122

2.  Comparison of conventional risk factors in middle-aged versus elderly diabetic and nondiabetic patients with myocardial infarction: prediction with decision-analytic model.

Authors:  Mohammad Reza Mahmoodi; Mohammad Reza Baneshi; Azam Rastegari
Journal:  Ther Adv Endocrinol Metab       Date:  2015-12       Impact factor: 3.565

Review 3.  Resistance to type 2 diabetes mellitus: a matter of hormesis?

Authors:  Hubert Kolb; Décio L Eizirik
Journal:  Nat Rev Endocrinol       Date:  2011-10-25       Impact factor: 43.330

4.  Polymorphisms of the reg1α gene and early onset type 2 diabetes in the korean population.

Authors:  Bo Kyung Koo; Young Min Cho; Kuchan Kimm; Jong-Young Lee; Bermseok Oh; Byung Lae Park; Hyun Sub Cheong; Hyoung Doo Shin; Kyung Soo Ko; Sang Gyu Park; Hong Kyu Lee; Kyong Soo Park
Journal:  Korean Diabetes J       Date:  2010-08-31

5.  Obesity in Irish youth: epidemiology and implications.

Authors:  F M Finucane
Journal:  Ir J Med Sci       Date:  2009-06-03       Impact factor: 1.568

6.  Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training.

Authors:  N Burns; F M Finucane; M Hatunic; M Gilman; M Murphy; D Gasparro; A Mari; A Gastaldelli; J J Nolan
Journal:  Diabetologia       Date:  2007-03-29       Impact factor: 10.122

7.  Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus.

Authors:  Peter J Donovan; H David McIntyre
Journal:  Diabetes Metab Syndr Obes       Date:  2010-11-16       Impact factor: 3.168

8.  Age differences in diabetes-related complications and glycemic control.

Authors:  S M Shamshirgaran; A Mamaghanian; A Aliasgarzadeh; N Aiminisani; M Iranparvar-Alamdari; J Ataie
Journal:  BMC Endocr Disord       Date:  2017-05-04       Impact factor: 2.763

9.  Initiating Characteristics of Early-onset Type 2 Diabetes Mellitus in Chinese Patients.

Authors:  Hui Yu; Li-Fang Xie; Kang Chen; Gang-Yi Yang; Xiao-Yan Xing; Jia-Jun Zhao; Tian-Pei Hong; Zhong-Yan Shan; Hong-Mei Li; Bing Chen; Xu-Lei Tang; Ling Qi; Jing Yang; Yuan Fang; Ting Li; Shuang-Shuang Wang; Xue Liang; Ya-Qi Yin; Yi-Ming Mu
Journal:  Chin Med J (Engl)       Date:  2016-04-05       Impact factor: 2.628

10.  Rationale and design of the randomised controlled trial to assess the impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes (the LYDIA study).

Authors:  Z Z Htike; T Yates; E M Brady; D Webb; L J Gray; D Swarbrick; G P McCann; K Khunti; M J Davies
Journal:  Cardiovasc Diabetol       Date:  2016-07-21       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.